Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Applications are invited for the 2018 Jill and Herbert Hunt Travelling Scholarship to support travel abroad for clinical study or research from graduates of the Oxford University Medical School.

© Shutterstock

Image courtesy of Shutterstock

The scholarship is of the value of about £4,000 and may be held with another award. This scholarship is offered in every second year.

Eligibility to apply:

Candidates must either hold the Degrees of Bachelor of Medicine and Bachelor of Surgery of the University of Oxford or have passed the First Examination for the Degree of Bachelor of Medicine of the University and hold a medical degree of another British university qualifying him or her to practise medicine. Current medical students are not eligible to apply; an award can only be made to an Oxford medical graduate who fulfils the above criteria.

Candidates are required to submit:

  • A letter of application outlining why they wish to apply for the scholarship and details of their proposed period of study, including an undertaking that, if elected, they will travel abroad for a period of at least one month for the purpose of clinical study or research in medicine
  • An estimate of the costs of the proposed period of clinical study or research
  • A statement of their academic record/CV
  • Two testimonals in support of the candidate/application.

The scholar will be required to complete his or her period of travel within twelve months from the date of election, and within a reasonable period thereafter to submit to the Secretary of the Medical School for the approval of the electors a detailed report of his or her tenure of the scholarship. Payment of nine-tenths of the scholarship will be made shortly before the period of travel, and the remaining one-tenth following the approval of the report. The election will be made on 8 April 2018.

Applications should be sent to Laura Morgan, Medical School Office, Academic Centre, Level 2, John Radcliffe Hospital, Headington, Oxford, OX3 9DU. E-mail: laura.morgan@medsci.ox.ac.uk.

The closing date for applications will be 16 February 2018.

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.